|
🐢
|
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
8 auth.
D. Mukerjee,
D. S. George,
B. Coleiro,
C. Knight,
C. Denton,
J. Davar,
...
C. Black,
J. G. Coghlan
|
9 |
2003 |
9
🐢
|
|
🐜
|
Pulmonary hypertension due to left heart diseases.
15 auth.
J. Vachiéry,
Y. Adir,
J. Barberà,
H. Champion,
J. G. Coghlan,
V. Cottin,
T. De Marco,
N. Galiè,
S. Ghio,
J. Gibbs,
...
F. Martinez,
M. Semigran,
G. Simonneau,
A. Wells,
W. Seeger
|
9 |
2013 |
9
🐜
|
|
🐢
|
Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis.
8 auth.
D. Mukerjee,
D. S. George,
C. Knight,
J. Davar,
A. Wells,
R. Bois,
...
C. Black,
J. G. Coghlan
|
8 |
2004 |
8
🐢
|
|
🐜
|
Pulmonary hypertension in chronic lung diseases.
15 auth.
W. Seeger,
Y. Adir,
J. Barberà,
H. Champion,
J. G. Coghlan,
V. Cottin,
T. De Marco,
N. Galiè,
S. Ghio,
S. Gibbs,
...
F. Martinez,
M. Semigran,
G. Simonneau,
A. Wells,
J. Vachiéry
|
8 |
2013 |
8
🐜
|
|
🐢
|
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
10 auth.
M. H. Williams,
C. Handler,
Raza Akram,
Colette Smith,
C. Das,
J. Smee,
...
D. Nair,
C. Denton,
C. Black,
J. G. Coghlan
|
8 |
2006 |
8
🐢
|
|
🐜
|
[Pulmonary hypertension in chronic lung diseases].
15 auth.
W. Seeger,
Y. Adir,
J. Barberà,
H. Champion,
J. G. Coghlan,
V. Cottin,
T. De Marco,
N. Galiè,
S. Ghio,
S. Gibbs,
...
F. Martinez,
M. Semigran,
G. Simonneau,
A. Wells,
Jean-Luc Vachiéy
|
8 |
2014 |
8
🐜
|
|
🐢
|
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
9 auth.
M. Williams,
C. Das,
C. Handler,
Mohammed R Akram,
J. Davar,
C. Denton,
...
Colette Smith,
C. Black,
J. G. Coghlan
|
7 |
2005 |
7
🐢
|
|
🐜
|
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival.
7 auth.
A. Macgregor,
R. Canavan,
C. Knight,
C. Denton,
J. Davar,
J. G. Coghlan,
...
C. Black
|
7 |
2001 |
7
🐜
|
|
🐜
|
Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension
9 auth.
R. Condliffe,
D. Kiely,
J. Gibbs,
P. Corris,
A. Peacock,
D. Jenkins,
...
K. Goldsmith,
J. G. Coghlan,
J. Pepke-Zaba
|
7 |
2008 |
7
🐜
|
|
🐢
|
Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.
C. Valerio,
B. Schreiber,
C. Handler,
C. Denton,
J. G. Coghlan
|
7 |
2013 |
7
🐢
|
|
🐢
|
Natriuretic peptides, respiratory disease, and the right heart.
L. Yap,
D. Mukerjee,
P. Timms,
H. Ashrafian,
J. G. Coghlan
|
7 |
2004 |
7
🐢
|
